Express Pharma

FEBRUARY 16, 2025

The number of patients living with obesity keeps growing, and following the recent advances in the therapeutic space, more patients are being prescribed pharmacotherapy on top of the usual diet and exercise lifestyle changes, which by themselves are often unsuccessful. With physicians and patients awareness expected to increase, sales of obesity medications are forecast to reach $173.5 billion in the seven major markets (7MM*) by 2031, according to GlobalData.

105

105

Pharmacy Joe

FEBRUARY 16, 2025

In this episode, I’ll discuss the impact of compounded oral vancomycin liquid on hospital readmission for C diff infection. Episode 1001: Saving Money on Oral Vancomycin Is Great For Inpatients But Can Cause Problems On Discharge Subscribe on iTunes , Android , or Stitcher The drug acquisition cost for oral vancomycin capsules is several orders of magnitude larger than for liquid vancomycin prepared from the IV formulation and given via the oral route.

Inpatient 52

Inpatient Community Pharmacies Hospitals Compounding 52

Pharmacy Times

FEBRUARY 16, 2025

Amlenetug could provide a treatment option for patients with multiple system atrophy, a progressive and rare condition that causes damage to the brains nerve cells.

29

29

STAT

FEBRUARY 16, 2025

The path from the atrocities of Nuremberg and Tuskegee to today’s robust ethics of medical research has not been easy. In response to these horrific events, a remarkable global consensus emerged, across countries in very different parts of the world and with very different types of governments: Medical researchers, and the institutions and companies who fund their work, are bound by a series of ethical obligations.

363

363

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmacy Times

FEBRUARY 16, 2025

DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.

29

29

Drug Patent Watch

FEBRUARY 16, 2025

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, pharmaceutical companies are looking for innovative ways to stay ahead of the competition. One strategy that's gaining traction is biosimilar-to-biosimilar switching. But what does this mean, and how can you make it work for your business? Biosimilar-to-biosimilar switching involves switching patients from one biosimilar to another, often to improve efficacy, reduce costs, or enhance patient o

Biosimilars 80

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 80

Med Ed 101

FEBRUARY 16, 2025

It can be overwhelming walking into the pharmacy and looking down the vitamin aisle especially when you finally find a specific supplement, only to discover there are numerous forms lining the shelves. This gets even more challenging when you dont know which salt form will be the most beneficial for your specific needs.We wanted […] The post Comparison of Magnesium Supplements – Which One To Choose?

52

52

STAT

FEBRUARY 16, 2025

Sweeping layoffs are set to hit federal health and science agencies , including at the National Institutes of Health, and former director Monica Bertagnolli called the situation at the NIH “devastating.” “We’re going to lose the next generation, that is the most difficult loss. This just sends, sends a chill,” Bertagnolli told STAT in an interview Saturday on the sidelines of the American Association for the Advancement of Science annual meeting in Boston.

Communication 363

Communication 363

STAT

FEBRUARY 16, 2025

WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are scrambling for ways to keep tabs on hospitals and insurers that are embracing the technologies. The terminations, with their potential to halt or hobble AI regulation, have caused alarm both inside and outside the agency, according to people interviewed by STAT.

Hospitals 363

Hospitals 363